Patient’s Name
Today’s Date
To save a PDF:
Click "Print", and select "Print to PDF"
REVEAL 2.0 Risk Calculator
Select all variables that apply. A minimum of 7 variables are required to generate a score. Calculation accuracy increases with more selections.
WHO Group 1 Subgroup
Demographics -
Male age > 60 years
eGFR<60mL/min/1.73m² or renal insufficiency
Functional Class
Systolic BP (mm Hg)
Heart Rate (BPM)
All-Cause Hospitalizations ≤ 6 mo
6-Minute Walk Test (m)
BNP (pg/mL)
NT-proBNP (pg/mL)
Pericardial Effusion on Echocardiogram
% predicted DLCO ≤40
mRAP >20 mm Hg Within 1 Year
PVR < 5 Wood units on right heart catheterization
Risk score
Low risk
Intermediate risk
High risk
Risk score
Sponsored by United Therapeutics
Committed to Improving the Lives of Patients
All use subject to terms and conditions at
APAH=associated pulmonary arterial hypertension; BNP=B-type natriuretic peptide; BPM=beats per minute; CTD=connective tissue disease;DLCO=diffusing capacity of the lung for carbon monoxide; eGFR=estimated glomerular filtration rate; FPAH=familial pulmonary atrial hypertension; HR=heart rate; mRAP=mean right arterial pressure; NT-proBNP=N-terminal pro-B-type natriuretic peptide; NYHA=New York Heart Association; PAH=pulmonary arterial hypertension; PoPH=portopulmonary hypertension; PVR=pulmonary vascular resistance; REVEAL=Registry to EValuate Early And Long-term pulmonary arterial hypertension disease management; SBP=systolic blood pressure; WHO=World Health Organization
Reference: Benza RL, et al. Chest. 2019;156(2):323-337.
©2020 United Therapeutics Corporation. All rights reserved. US-DS-0551